Patent ID: 8022104

Claim:
An oral pharmaceutical composition comprising R(+)-6-(N-methyl, N-ethyl-carbamoyloxy)-N′-propargyl-1-aminoindan hemitartrate in an amount of 25 mg to 105 mg, at least one pharmaceutically acceptable excipient and up to 5% by weight of the composition of water, wherein the at least one pharmaceutically acceptable excipient is mannitol as a first filler being present in an amount of 6 to 16% by weight, mannitol granulate as a second filler being present in an amount of 0 to 56% by weight, starch as a disintegrant being present in an amount of 15 to 38% by weight, colloidal silicon dioxide as a flow agent being present in an amount of 1 to 2% by weight, and polyvinylpyrolidone as a binder being present in an amount of 3 to 8% by weight.